Stifel on Insmed (INSM): UTHR trial meeting endpoint removes overhang for INSM
Go back to Stifel on Insmed (INSM): UTHR trial meeting endpoint removes overhang for INSM| INSMED (NASDAQ: INSM) | Delayed: 102.15 +3.54 (3.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $98.61 | 52 Week High | $19.30 | |||
| Open | $98.84 | 52 Week Low | $9.02 | |||
| Day High | $103.15 | P/E | N/A | |||
| Day Low | $97.60 | EPS | $-1.69 | |||
| Volume | 4,199,721 | |||||
